Depending on the molecular and genetic information from the tumors, breast cancer can be divided into 4 major subtypes. Each subtype is associated with different prognosis and should be taken into consideration when making treatment decisions. In this issue of the iJournal of Clinical Investigation/i, Rebecca Cook and colleagues at Vanderbilt University, found that expression of an oncogene, iERBB3/i, was enhanced in luminal breast cancers compared to other ...You have just read an article categorized health
titled Response to Antiestrogen Therapy Enhanced in Luminal Breast Tumor.
Written by:
editor - Thursday, September 5, 2013
There are currently no comments for "Response to Antiestrogen Therapy Enhanced in Luminal Breast Tumor"
Post a Comment